Collaborative Arrangements (Tables)

6 Months Ended

Jun. 30, 2011

Collaborative Arrangements

Collaborative Arrangements

		Three Months Ended June 30,					Six Months Ended June 30,
		2011			2010		2011			2010
		(in thousands)
Amortized portion of up-front payment		$	3,107		$	3,107	$	6,214		$	6,214
Milestone revenues			—			—		50,000			—
Net reimbursement (payment) for telaprevir development costs			(3,108	)		3,501		(4,253	)		5,907
Reimbursement for manufacturing services			9,059			5,274		13,213			6,225
	Total collaborative revenues attributable to the Janssen collaboration	$	9,058		$	11,882	$	65,174		$	18,346

 

		Three Months Ended June 30,				Six Months Ended June 30,
		2011		2010		2011		2010
		(in thousands)
Amortized portion of up-front payments		$	9,558	$	9,558	$	19,116	$	19,116
Development milestone revenues			182		—		1,394		—
Payments for manufacturing services			5,133		2,478		5,848		2,478
	Total collaborative revenues attributable to the Mitsubishi Tanabe collaboration	$	14,873	$	12,036	$	26,358	$	21,594

Summary of fair values of consideration paid or payable by the Company pursuant to the Alios Agreement

		As of June 13, 2011
		(in thousands)
Up-front payment		$	60,000
Fair value of contingent milestone and royalty payments			197,720
	Total	$	257,720

Summarizes the consideration paid or the preliminary fair values of the contingent consideration recorded on the effective date of the Alios Collaboration

		Preliminary Fair Values as of June 13, 2011
		(in thousands)
Intangible assets		$	250,600
Goodwill			7,399
Deferred tax liability (net)			(90,840	)
Net other assets (liabilities)			(279	)
	Net assets attributable to noncontrolling interests (Alios)	$	166,880

Summary of activity Related to net loss attributable to noncontrolling interest of Alios Collaboration

		Three Months Ended June 30, 2011
		(in thousands)
Loss of noncontrolling interest (Alios) before provision for income taxes		$	(801	)
Income tax provision (Alios)			(24,448	)
Change in fair value of contingent milestone and royalty payments			—
	Net loss attributable to noncontrolling interest (Alios)	$	(25,249	)

Summarizes Alios' assets and liabilities included in the Company's condensed consolidated balance sheets

	As of June 13, 2011		As of June 30, 2011
	(in thousands)
Restricted cash and cash equivalents (Alios)	$	4,575	$	63,098
Prepaid expenses and other current assets		69		120
Property and equipment, net		885		1,012
Intangible assets		250,600		250,600
Goodwill		7,399		7,399
Other assets		76		76
Accounts payable		1,189		2,038
Accrued expenses and other current liabilities		1,504		967
Income taxes payable (Alios)		—		15,212
Deferred tax liability, net		90,840		100,076
Other liabilities		3,191		3,188
Redeemable noncontrolling interest (Alios)		36,299		36,299
Noncontrolling interest (Alios)		130,581		105,332